Real-time enrollment status for this major depressive disorder clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 5:52 AM UTC
| NCT Number | NCT06963021 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder |
| Phase | PHASE3 |
| Target Enrollment | 200 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Neurocrine Biosciences |
| Last Updated on CT.gov | August 10, 2026 (Aug 10, 2026) |
As of October 15, 2026: Clinical trial NCT06963021 is currently recruiting participants. This phase3 study for major depressive disorder is actively seeking new participants at 15 locations across the United States. The study is sponsored by Neurocrine Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06963021 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06963021 was last updated Aug 10, 2026 (August 10, 2026). HelloStudys verifies this status automatically.